Aprecap 150 mg Injection is the neurokinin-1 antagonist class of medications. It is available in oral capsule form and liquid suspension for pediatric patients or those who cannot take it orally. APREPITANT is used to treat nausea and vomiting post surgical and post chemotherapy.

• CINV ( Chemotherapy induced nausea
• PONV ( Post operative nausea and vomiting)

The main benefits of using Aprecap 150 mg Injection are, Treating vomiting and nausea for patients already treated with chemotherapy or surgery. Aprecap 150 mg Injection is available in oral capsule form and suspension form, so its too easy to take to swallow easily.

• Bloating of abdomen
• Stomach pain
• Hiccups

• Dizziness
• Weakness
• Tiredness
• Diarrhoea
• Constipation
• Heartburn
• Epigastric pain

• Allergic skin reaction
• Severe Itching
• Difficulty in breathing
• Difficulty in swallowing

Aprecap 150 mg Injection is available as an oral capsule form and suspension (liquid) form which can be taken orally. It can be taken with or without food as directed by your doctor.

The action of the Aprecap 150 mg Injection is mediated by three G protein- coupled tachykinin receptors designated NK1, NK2 and NK3. Substance P is the preferred ligand for the NK1 receptor, the predominant tachykinin receptor in the human brain. Nk1 is a G protein-coupled receptor located in the central and peripheral nervous system. It is found in high concentration in the vomiting center of the brain. It also plays a key role in the transmission of pain impulses from the peripheral receptors to the CNS.